2013 PDA/FDA Pharmaceutical Supply Chain Workshop

Published: 5-Apr-2013

3 - 5 June 2013

Workshop

Hyatt Regency, Bethesda, MD, US


This workshop and exhibition will explore many critical aspects that drive a pharmaceutical supply chain including globalisation, product stewardship and regulatory pressures.

Organiser: PDA/FDA

Trending Articles

  1. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  2. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  3. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  4. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  5. KOREA CHEM 2023 18-21 April 2023 | Exhibition | Korea

You may also like

Manufacturing

What's in an FDA approval? How a start-up company gets its drug to market

The FDA wields a supreme amount of power in the regulatory realm of the pharmaceutical industry. For smaller start-ups or those newer to the industry, navigating the compliance pathways can prove a daunting task
Regulatory

FDA grants landmark approval for Alzheimer’s treatment

LEQEMBI is the first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease
Regulatory

Sequana submits IND application for heart failure treatment

The IND application includes data from the previously reported GLP animal and Phase 1 CHIHUAHUA studies
Regulatory

FDA grants marketing approval for safety syringes

Zephyrus' needle system contains an internal mechanism that retracts the needle inside the syringe after activation
Regulatory

ICH Q12 toolbox and change management

With present day circumstances including the pandemic affecting almost all sectors of society, the pharmaceutical industry is gravitating towards a complete revision of the traditional manufacturing environment. Connie Leech, Global Director of Quality, Compliance and Regulatory Services at CAI, reports
Regulatory

FDA releases final guidance for upcoming biological product transition

The BPCI Act requires that a marketing application for a “biological product” must be submitted as a biologics license application
Personal Protection

Coronavirus: Emergency planning for the drug supply chain

The FDA has outlined its expectations and actions regarding supply chain and inspections in China
Subscribe now